We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
    • Webinar Recordings
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FDA Warns of Smart Rings, Smartwatches That Claim to Measure Blood Glucose Levels

FDA Warns of Smart Rings, Smartwatches That Claim to Measure Blood Glucose Levels

February 26, 2024

Smartwatches and smart rings that claim to measure blood glucose levels without piercing the skin have not been authorized, cleared or approved by the FDA, the agency has warned in a recent safety communication.

“Sellers of these smartwatches and smart rings claim their devices measure blood glucose levels without requiring people to prick their finger or pierce the skin,” the FDA said. The to-be-avoided smartwatches and smart rings are “manufactured by dozens of companies and sold under multiple brand names,” the agency explained, and available through online marketplaces and directly from sellers.

The agency advises that inaccurate blood glucose measurements can lead to errors such as taking the wrong dose of insulin or other medications that can rapidly lower blood glucose. “Taking too much of these medications can quickly lead to dangerously low glucose, leading to mental confusion, coma, or death within hours of the error,” the FDA said.

Read the FDA’s safety communication here.

To read the whole story, click here to subscribe.

Related Topics

Devices Regulatory Affairs

    Upcoming Events

    • 29Feb

      ICH Q10 Pharmaceutical Quality System — Unpacked and Refreshed

    • 14Mar

      From QSR to QMSR: Meeting FDA’s New Requirements

    • 21Mar

      FDA as a Development Partner: A New Approach to Product Review Meetings

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • FDA, FTC and DOJ Enforcement of Medical Device Regulations

      FDA, FTC and DOJ Enforcement of Medical Device Regulations

    • Using Real-World Evidence in Drug and Device Submissions

      Using Real-World Evidence in Drug and Device Submissions

    Featured Stories

    • Warning Letter Says Chinese Firm Must Comply With Remediation or Face Import Ban

    • FDA’s Regulation of Devices Should Be More Active, Say Academicians

    • Five Companies Won’t Delist Orange Book Patents Challenged by FTC, Three Others Will

    • FDA Warns of Smart Rings, Smartwatches That Claim to Measure Blood Glucose Levels

    The Revised ICH E8: A Guide to New Clinical Trial Requirements

    Learn More
    • Drug Products
      • Quality
      • Regulatory Affairs
      • GMPs
      • Inspections and Audits
      • Postmarket Safety
      • Submissions and Approvals
      • Research and Development
      • Commercial Operations
    • Device Products
      • Quality
      • Regulatory Affairs
      • QSR
      • Inspections and Audits
      • Postmarket Safety
      • Submissions and Approvals
      • Research and Development
      • Commercial Operations
    • Clinical Products
      • Trial Design
      • Data Integrity
      • GCP
      • Inspections and Audits
      • Transparency
    • Privacy Policy
    • Do Not Sell or Share My Data
    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing